Sun Pharma Advanced Research Company Ltd.
|
QUARTERLY RESULTS
|
|
You can view the
Quaterly Results
for the last 5 years.
Market Cap. (Rs.)
|
7113.51 Cr.
|
P/BV
|
13.87
|
Book Value (Rs.)
|
15.80
|
52 Week High/Low (Rs.)
|
473/179
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 13.86 | 21.18 | 23.95 |
Total Income From Operations | 13.86 | 21.18 | 23.95 |
| | | |
EXPENDITURE | | | |
Consumption of Raw Materials | 9.03 | 6.47 | 5.17 |
Employees Cost | 29.96 | 30.71 | 31.12 |
Depreciation | 3.16 | 3.18 | 3.10 |
Other Expenses | 77.49 | 75.47 | 89.84 |
Total Expenses | 119.64 | 115.83 | 129.23 |
| | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | -105.78 | -94.65 | -105.28 |
Other Income | 6.39 | 8.49 | 10.19 |
P/L Before Interest, Excpt. Items & Tax | -99.39 | -86.16 | -95.09 |
Interest | 0.26 | 0.26 | 0.26 |
P/L Before Exceptional Items & Tax | -99.65 | -86.42 | -95.35 |
P/L Before Tax | -99.65 | -86.42 | -95.35 |
P/L After Tax from Ordinary Activities | -99.65 | -86.42 | -95.35 |
Net Profit/Loss For the Period | -99.65 | -86.42 | -95.35 |
Net P/L After Minority Interest & Share Of Associates | -99.65 | -86.42 | -95.35 |
| | | |
Equity Share Capital | 32.45 | 32.45 | 32.45 |
EPS Before Extra Ordinary * | | | |
Basic EPS (Rs.) | -3.07 | -2.66 | -2.94 |
Diluted EPS (Rs.) | -3.07 | -2.66 | (2.94) |
EPS After Extra Ordinary * | | | |
Basic EPS (Rs.) | -3.07 | -2.66 | -2.94 |
Diluted EPS (Rs.) | -3.07 | -2.66 | (2.94) |
| | | |
PBITOE Margin (%) | -763.20 | -446.88 | -439.58 |
PBTE Margin (%) | -718.97 | -408.02 | -398.12 |
PBT Margin (%) | -718.97 | -408.02 | -398.12 |
PAT Margin (%) | -718.97 | -408.02 | -398.12 |
PAT After MI And SOA Margin (%) | -718.97 | -408.02 | -398.12 |